NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/01/2026
Voltar para busca
Dado oficial do USPTO
NAVIFY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
53
Atualização mais recente
06/01/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
35, 42
Data de depósito
05/04/2018
Data de registro
03/12/2019
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
05/01/2026
Última transação
06/01/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
30/09/2018
Primeiro uso no comércio
30/09/2018
Código do desenho
4
Tipo de titular
16
Localização do titular
MANNHEIM, DE
Examinador
PINO, BRIAN
Localização atual
Historical data usage
Titulares e representantes
Titulares
Roche Diagnostics GmbH
Roche Diagnostics GmbH
Roche Diagnostics GmbH
Representantes
Mona Gupta Roche Diagnostics Operations, Inc.
Classificação técnica
Classes Nice
Classe 35Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 35
Promoting collaboration within the scientificresearch and medical communities to achieve advances in the fields of nucleic acid sequencing and genotypingmedical diagnosticsclinical diagnosticsmedical researchclinical researchlife sciencesbiologymolecular pathologymolecular diagnosticslaboratory medicinebiotechnologyagricultureforensicsgenetics; computer-based updating and maintenance of data in databasesall in the pharmaceutical and/or healthcare sector; electronic data collection and compilation of scientific and statistical information into computer databases in the field of medicine and healthcare; analyzing and compiling business data for healthcare solutions
Classe 42
Compiling scientific and or clinical datain particular patient data and data from clinical studiesfor research purposes in the fields of nucleic acid sequencing and genotypingmedical diagnosticsclinical diagnosticsmedical researchclinical researchlife sciencesbiologymolecular pathologymolecular diagnosticslaboratory medicinebiotechnologyagricultureforensicsgenetics
Publicações
Histórico de despachos e eventos da marca no USPTO.
53 publicações encontradas
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/01/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/12/2025
E815
TEAS SECTION 8 & 15 RECEIVED
25/09/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/09/2024
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/09/2024
EWOR
TEAS WITHDRAWAL AS DOMESTIC REPRESENTATIVE RECEIVED
10/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/09/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/10/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/10/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/10/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/10/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
05/12/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
05/12/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
03/12/2019
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
31/10/2019
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
30/10/2019
SUPC
STATEMENT OF USE PROCESSING COMPLETE
24/10/2019
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
24/10/2019
IUAF
USE AMENDMENT FILED
04/10/2019
EISU
TEAS STATEMENT OF USE RECEIVED
04/10/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/10/2019
EX2G
SOU EXTENSION 2 GRANTED
02/10/2019
EXT2
SOU EXTENSION 2 FILED
02/10/2019
EEXT
SOU TEAS EXTENSION RECEIVED
02/10/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/10/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/10/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/04/2019
EX1G
SOU EXTENSION 1 GRANTED
29/03/2019
EXT1
SOU EXTENSION 1 FILED
29/03/2019
EEXT
SOU TEAS EXTENSION RECEIVED
29/03/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
14/01/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
14/01/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/10/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
07/08/2018
PUBO
PUBLISHED FOR OPPOSITION
07/08/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
18/07/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/07/2018
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/07/2018
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2018
ALIE
ASSIGNED TO LIE
28/06/2018
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
14/06/2018
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/05/2018
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
03/05/2018
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
03/05/2018
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
03/05/2018
DOCK
ASSIGNED TO EXAMINER
26/04/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
13/04/2018
NWAP
NEW APPLICATION ENTERED
09/04/2018
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace NAVIFY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.